[Re-188]Sodium perrhenate

高铼[Re-188]酸钠

Report date: 2025/12/01 17:16:52
NME

Base Information

Drug Name[Re-188]Sodium perrhenate
Drug Alias NameN/A
ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Rhenium > 188ReSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesShanghai Atom Kexing Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Atom Kexing Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A